{"gene":"DRD3","run_date":"2026-06-09T23:54:42","timeline":{"discoveries":[{"year":2017,"finding":"Drd3 signaling in lateral septum (LS) neurons is necessary and sufficient for normal social behavior; ELS-induced downregulation of Drd3 blunts activity of Drd3-expressing LS neurons in response to social stimuli, and optogenetic activation of Drd3LS neurons or pharmacological Drd3 agonism rescues ELS-induced social impairments.","method":"In vivo Ca2+ imaging, optogenetics, pharmacological agonism, viral-mediated knockdown, behavioral assays in mice","journal":"Neuron","confidence":"High","confidence_rationale":"Tier 2 / Strong — multiple orthogonal methods (in vivo imaging, optogenetics, pharmacology, KD) in a single rigorous study with defined cellular and behavioral phenotypes","pmids":["29276054"],"is_preprint":false},{"year":2021,"finding":"DRD3-dependent plasticity in the ventral pallidum (VP) drives potentiation of nucleus accumbens dopamine release during relapse to cocaine seeking; two distinct VP DRD3+ neuronal populations project to lateral habenula (LHb) or VTA with different activity patterns during drug seeking, and selective suppression of LHb-projecting population activity or DRD3 signaling reduces cocaine seeking.","method":"Circuit-specific optogenetics, DRD3 signaling suppression, dopamine release measurements, cocaine self-administration/relapse paradigm in mice","journal":"Neuron","confidence":"High","confidence_rationale":"Tier 2 / Strong — multiple orthogonal circuit-dissection methods with defined behavioral and neurochemical readouts in a single rigorous study","pmids":["34048697"],"is_preprint":false},{"year":2014,"finding":"NPAS2, a circadian transcription factor, directly binds the Drd3 promoter and drives its diurnal rhythmic expression in nucleus accumbens D1-expressing neurons; Npas2 knockdown in NAc disrupts Drd3 diurnal rhythm and decreases cocaine reward, whereas CLOCK knockdown has no effect.","method":"Chromatin immunoprecipitation followed by deep sequencing (ChIP-seq), AAV-shRNA knockdown in NAc, conditioned place preference assay, cell-sorting qRT-PCR","journal":"Biological psychiatry","confidence":"High","confidence_rationale":"Tier 2 / Strong — ChIP-seq identifies direct binding site, complemented by in vivo knockdown with behavioral and molecular readouts, single lab but multiple orthogonal methods","pmids":["25444159"],"is_preprint":false},{"year":2019,"finding":"DRD3 (but not DRD2) activates autophagy through an AMPK → inhibitory phosphorylation of RPTOR → MTORC1 inhibition → ULK1 activation pathway; despite MTORC1 inhibition, DRD3 preserves protein synthesis via the MAPK1/3–RPS6KA pathway, distinguishing it from direct mTOR inhibitors.","method":"DRD3/DRD2-overexpressing cells, drd3 KO and drd2 KO mice, pramipexole treatment, Western blot for autophagy/mTOR pathway components, GFP-LC3 puncta assay","journal":"Autophagy","confidence":"High","confidence_rationale":"Tier 1–2 / Strong — genetic KO models plus receptor-overexpression, in vitro and in vivo concordance, multiple pathway readouts; single lab but rigorous mechanistic dissection","pmids":["31538542"],"is_preprint":false},{"year":2022,"finding":"PPX (pramipexole) suppresses NLRP3 inflammasome activation in astrocytes via a Drd3-dependent enhancement of autophagy; Drd3 depletion abolishes PPX-induced autophagy and NLRP3 suppression, and astrocyte-specific Atg5 knockdown blocks PPX neuroprotection in a mouse PD model.","method":"Drd3 siRNA depletion in primary astrocytes, LPS/ATP inflammasome stimulation, LC3-II/BECN1 western blot, GFP-LC3 puncta, astrocyte-specific Atg5 knockdown in vivo, LPS PD mouse model","journal":"Acta pharmacologica Sinica","confidence":"High","confidence_rationale":"Tier 2 / Strong — genetic loss-of-function (siRNA and in vivo Atg5 KD) with concordant in vitro and in vivo readouts, multiple orthogonal approaches, single lab","pmids":["35896696"],"is_preprint":false},{"year":2016,"finding":"DRD3 palmitoylation acts as a molecular switch for biased signaling: palmitoylation of the Drd3 C-terminal cytoplasmic domain exposes a docking site for the scaffold protein GIPC1, redirecting receptor trafficking and signaling; disruption of palmitoylation or GIPC1 interaction alters Drd3 internalization and downstream signaling.","method":"Molecular dynamics simulation, Co-IP/biochemical interaction studies, live-cell imaging, site-directed mutagenesis of palmitoylation/GIPC1-binding sites in cultured cells","journal":"Molecular and cellular biology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — combines computational modeling with biochemical pulldown, live imaging, and mutagenesis; single lab, mechanistic but abstract-level detail limits full Tier 1 assignment","pmids":["26787837"],"is_preprint":false},{"year":2004,"finding":"DRD3 mediates expression of conditioned rewarding effects of morphine: in drd3 knockout mice, morphine conditioned place preference (CPP) is retained but the DRD3-selective partial agonist BP897 fails to inhibit CPP expression, and BP897 reduces c-fos activation in somatosensory cortex only in wild-type mice.","method":"drd3 knockout mice, conditioned place preference, c-fos imaging, pharmacological intervention with BP897","journal":"Neuroreport","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — clean genetic KO with pharmacological probe and brain imaging readout; single lab, moderate method breadth","pmids":["15371743"],"is_preprint":false},{"year":2013,"finding":"The DRD3 Ser9Gly (Gly allele) functional missense variant is associated with greater reward-related striatal dopamine release (measured as increased displacement of [11C]raclopride) during unpredictable monetary reward in the anterior caudate and ventral striatum, consistent with Gly-form D3 autoreceptors having higher DA affinity and more robust intracellular signaling.","method":"PET with [11C]raclopride bolus-plus-infusion in humans during gambling vs. sensorimotor task, linear regression controlling for age, sex, diagnosis","journal":"PloS one","confidence":"Medium","confidence_rationale":"Tier 2 / Weak — direct in vivo DA release measurement in humans with genotype stratification; single lab, single method, modest sample size (n=36)","pmids":["23365649"],"is_preprint":false}],"current_model":"DRD3 is a G protein-coupled dopamine receptor that (1) in the lateral septum mediates social behavior downstream of early-life stress by modulating neuronal activity; (2) in the ventral pallidum drives a pallido-habenular circuit potentiating accumbal dopamine release during cocaine relapse; (3) in the nucleus accumbens is a direct transcriptional target of the circadian factor NPAS2, coupling circadian rhythms to reward signaling; (4) activates autophagy via AMPK–MTORC1–ULK1 signaling while preserving protein synthesis through the MAPK/RPS6KA axis; (5) in astrocytes suppresses NLRP3 inflammasome activity through Drd3-dependent autophagy induction; and (6) undergoes palmitoylation that acts as a molecular switch recruiting GIPC1 to redirect receptor trafficking and biased signaling."},"narrative":{"mechanistic_narrative":"DRD3 is a G protein-coupled dopamine receptor that shapes reward, social behavior, and dopaminergic circuit plasticity while also coupling receptor signaling to autophagy and inflammasome control [PMID:29276054, PMID:31538542]. In the brain, Drd3 in lateral septum neurons is necessary and sufficient for normal social behavior, and its early-life-stress-induced downregulation blunts social-stimulus-evoked neuronal activity that optogenetic or pharmacological reactivation rescues [PMID:29276054]. Within reward circuitry, DRD3-dependent plasticity in the ventral pallidum drives a pallido-habenular projection that potentiates accumbal dopamine release during cocaine relapse [PMID:34048697], and Drd3 reward function is gated transcriptionally and temporally by the circadian factor NPAS2, which binds the Drd3 promoter to impose diurnal expression in nucleus accumbens D1 neurons [PMID:25444159]. At the signaling level, DRD3 — but not DRD2 — activates autophagy through an AMPK→RPTOR→MTORC1 inhibition→ULK1 cascade while preserving protein synthesis via the MAPK1/3–RPS6KA axis [PMID:31538542], and this Drd3-dependent autophagy suppresses NLRP3 inflammasome activation in astrocytes to confer neuroprotection [PMID:35896696]. Receptor trafficking and biased signaling are controlled by palmitoylation of the DRD3 C-terminal cytoplasmic domain, which exposes a docking site for the scaffold GIPC1 to redirect internalization [PMID:26787837].","teleology":[{"year":2004,"claim":"Established that DRD3 is required for the pharmacological modulation of morphine reward expression, linking the receptor to drug-conditioned behavior.","evidence":"drd3 knockout mice with morphine conditioned place preference, c-fos imaging, and BP897 pharmacology","pmids":["15371743"],"confidence":"Medium","gaps":["Does not define the circuit or cellular site of DRD3 action in reward","Mechanism of how BP897 reduces somatosensory c-fos is unresolved"]},{"year":2013,"claim":"Showed that a functional human DRD3 coding variant (Ser9Gly) alters reward-related striatal dopamine release, providing in vivo evidence that DRD3 autoreceptor function shapes human reward signaling.","evidence":"PET with [11C]raclopride during a reward task with DRD3 genotype stratification in humans","pmids":["23365649"],"confidence":"Medium","gaps":["Single modest-sample study without independent replication","Does not directly measure receptor affinity or signaling, only inferred from DA displacement"]},{"year":2014,"claim":"Identified the transcriptional and temporal control of DRD3 by demonstrating NPAS2 directly drives its diurnal rhythm in accumbal neurons, coupling circadian biology to reward.","evidence":"ChIP-seq, AAV-shRNA knockdown in NAc, conditioned place preference, cell-sorting qRT-PCR in mice","pmids":["25444159"],"confidence":"High","gaps":["Does not establish how diurnal Drd3 levels translate to circuit-level reward changes","Distinction from CLOCK control not mechanistically explained"]},{"year":2016,"claim":"Defined a post-translational switch for DRD3 signaling, showing that C-terminal palmitoylation recruits GIPC1 to bias receptor trafficking and downstream signaling.","evidence":"Molecular dynamics, Co-IP, live-cell imaging, and site-directed mutagenesis in cultured cells","pmids":["26787837"],"confidence":"Medium","gaps":["Abstract-level mechanistic detail without reconstitution","Identity of the palmitoyl transferase is not defined","Physiological consequence in neurons not tested"]},{"year":2017,"claim":"Demonstrated DRD3 is a necessary and sufficient driver of normal social behavior in lateral septum neurons and the molecular target of early-life-stress-induced social deficits.","evidence":"In vivo Ca2+ imaging, optogenetics, pharmacology, and viral knockdown in mice","pmids":["29276054"],"confidence":"High","gaps":["Downstream effectors of Drd3LS neuron activity in social behavior unresolved","Molecular mechanism of ELS-induced Drd3 downregulation not defined"]},{"year":2019,"claim":"Resolved a DRD3-specific intracellular signaling pathway, showing it activates autophagy via AMPK→RPTOR→MTORC1→ULK1 while uniquely sparing protein synthesis, distinguishing it from DRD2 and direct mTOR inhibitors.","evidence":"Receptor-overexpressing cells, drd3 and drd2 KO mice, pramipexole, autophagy/mTOR Western blots and GFP-LC3 assays","pmids":["31538542"],"confidence":"High","gaps":["Proximal G-protein coupling to AMPK activation not mapped","In vivo relevance of preserved protein synthesis not behaviorally tested"]},{"year":2021,"claim":"Mapped DRD3 plasticity to a defined ventral pallidum circuit, showing distinct VP DRD3+ populations projecting to LHb or VTA control accumbal dopamine potentiation during cocaine relapse.","evidence":"Circuit-specific optogenetics, DRD3 signaling suppression, dopamine release measurements, and cocaine relapse paradigm in mice","pmids":["34048697"],"confidence":"High","gaps":["Molecular nature of DRD3-dependent plasticity in VP not defined","Link to the accumbal NPAS2/Drd3 transcriptional axis untested"]},{"year":2022,"claim":"Connected DRD3 autophagy signaling to innate immune control, showing Drd3-dependent autophagy suppresses astrocytic NLRP3 inflammasome activity and confers neuroprotection.","evidence":"Drd3 siRNA in primary astrocytes, NLRP3 stimulation, autophagy markers, astrocyte-specific Atg5 knockdown in a mouse PD model","pmids":["35896696"],"confidence":"High","gaps":["Whether endogenous dopaminergic tone engages this astrocytic pathway is untested","Link between the AMPK-MTORC1 autophagy cascade and NLRP3 suppression not directly traced"]},{"year":null,"claim":"How DRD3's palmitoylation/GIPC1 trafficking switch, its AMPK-autophagy signaling, and its circuit-specific roles in social behavior and reward are integrated into a unified receptor-level mechanism remains open.","evidence":"","pmids":[],"confidence":"Medium","gaps":["No structural model linking palmitoylation state to specific signaling outputs","Whether biased signaling controls the autophagy versus circuit-plasticity branches is unknown"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0060089","term_label":"molecular transducer activity","supporting_discovery_ids":[0,1,3]}],"localization":[{"term_id":"GO:0005886","term_label":"plasma membrane","supporting_discovery_ids":[5]}],"pathway":[{"term_id":"R-HSA-162582","term_label":"Signal Transduction","supporting_discovery_ids":[0,1,3]},{"term_id":"R-HSA-9612973","term_label":"Autophagy","supporting_discovery_ids":[3,4]},{"term_id":"R-HSA-168256","term_label":"Immune System","supporting_discovery_ids":[4]},{"term_id":"R-HSA-9909396","term_label":"Circadian clock","supporting_discovery_ids":[2]}],"complexes":[],"partners":["GIPC1"],"other_free_text":[]}},"prefetch_data":{"uniprot":{"accession":"P35462","full_name":"D(3) dopamine receptor","aliases":["Dopamine D3 receptor"],"length_aa":400,"mass_kda":44.2,"function":"Dopamine receptor that is primarily expressed in limbic areas of the brain and is involved in the modulation of cognitive, emotional, and endocrine functions (PubMed:39984436). Plays a key role in regulating neuronal signaling pathways associated with motivation, reward, and behavior (PubMed:39984436). Coupled to G(i)/G(o) proteins; activation leads to inhibition of adenylate cyclase and decreased intracellular cAMP levels (PubMed:10578130). Involved in the control of locomotor activity and implicated in several neuropsychiatric disorders, including schizophrenia and substance use disorders (PubMed:39984436). Promotes cell proliferation through MAP kinase signaling (PubMed:19520868). Also involved in autophagy regulation: receptor activation stimulates AMPK, which phosphorylates RPTOR and enhances its interaction with MTOR, thereby inhibiting MTORC1 signaling and its downstream target RPS6KB1. This leads to activation of ULK1 and initiation of the autophagy cascade (PubMed:31538542). Forms heterotetramers with DRD1 to potentiate beta-arrestin recruitment and mediate locomotor activity (By similarity)","subcellular_location":"Cell membrane","url":"https://www.uniprot.org/uniprotkb/P35462/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/DRD3","classification":"Not Classified","n_dependent_lines":0,"n_total_lines":1208,"dependency_fraction":0.0},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/DRD3","total_profiled":1310},"omim":[{"mim_id":"615433","title":"CHROMOSOME 3q13.31 DELETION SYNDROME","url":"https://www.omim.org/entry/615433"},{"mim_id":"614655","title":"STUTTERING, FAMILIAL PERSISTENT, 3; STUT3","url":"https://www.omim.org/entry/614655"},{"mim_id":"601768","title":"SH3 DOMAIN, GRB2-LIKE, 1; SH3GL1","url":"https://www.omim.org/entry/601768"},{"mim_id":"190300","title":"TREMOR, HEREDITARY ESSENTIAL, 1; ETM1","url":"https://www.omim.org/entry/190300"},{"mim_id":"181500","title":"SCHIZOPHRENIA; SCZD","url":"https://www.omim.org/entry/181500"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"","locations":[],"tissue_specificity":"Tissue enriched","tissue_distribution":"Detected in single","driving_tissues":[{"tissue":"brain","ntpm":5.2}],"url":"https://www.proteinatlas.org/search/DRD3"},"hgnc":{"alias_symbol":[],"prev_symbol":[]},"alphafold":{"accession":"P35462","domains":[{"cath_id":"1.20.1070.10","chopping":"28-223_323-400","consensus_level":"high","plddt":90.3075,"start":28,"end":400}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/P35462","model_url":"https://alphafold.ebi.ac.uk/files/AF-P35462-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-P35462-F1-predicted_aligned_error_v6.png","plddt_mean":75.38},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=DRD3","jax_strain_url":"https://www.jax.org/strain/search?query=DRD3"},"sequence":{"accession":"P35462","fasta_url":"https://rest.uniprot.org/uniprotkb/P35462.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/P35462/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/P35462"}},"corpus_meta":[{"pmid":"19562769","id":"PMC_19562769","title":"Association of DRD3 and GRIN2B with impulse control and related behaviors in Parkinson's disease.","date":"2009","source":"Movement disorders : official journal of the Movement Disorder Society","url":"https://pubmed.ncbi.nlm.nih.gov/19562769","citation_count":130,"is_preprint":false},{"pmid":"29276054","id":"PMC_29276054","title":"Drd3 Signaling in the Lateral Septum Mediates Early Life Stress-Induced Social Dysfunction.","date":"2017","source":"Neuron","url":"https://pubmed.ncbi.nlm.nih.gov/29276054","citation_count":104,"is_preprint":false},{"pmid":"14681904","id":"PMC_14681904","title":"Role of dopamine D3 receptor (DRD3) and dopamine transporter (DAT) polymorphism in cognitive dysfunctions and therapeutic response to atypical antipsychotics in patients with schizophrenia.","date":"2004","source":"American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics","url":"https://pubmed.ncbi.nlm.nih.gov/14681904","citation_count":100,"is_preprint":false},{"pmid":"16513329","id":"PMC_16513329","title":"Antipsychotic-induced tardive dyskinesia and the Ser9Gly polymorphism in the DRD3 gene: a meta analysis.","date":"2006","source":"Schizophrenia research","url":"https://pubmed.ncbi.nlm.nih.gov/16513329","citation_count":96,"is_preprint":false},{"pmid":"20100784","id":"PMC_20100784","title":"Implication of the env gene of the human endogenous retrovirus W family in the expression of BDNF and DRD3 and development of recent-onset schizophrenia.","date":"2010","source":"Schizophrenia bulletin","url":"https://pubmed.ncbi.nlm.nih.gov/20100784","citation_count":91,"is_preprint":false},{"pmid":"9674978","id":"PMC_9674978","title":"Meta-analysis of DRD3 gene and schizophrenia: ethnic heterogeneity and significant association in Caucasians.","date":"1998","source":"American journal of medical genetics","url":"https://pubmed.ncbi.nlm.nih.gov/9674978","citation_count":90,"is_preprint":false},{"pmid":"19464960","id":"PMC_19464960","title":"DRD3 Ser9Gly polymorphism is related to thermal pain perception and modulation in chronic widespread pain patients and healthy controls.","date":"2009","source":"The journal of pain","url":"https://pubmed.ncbi.nlm.nih.gov/19464960","citation_count":80,"is_preprint":false},{"pmid":"25444159","id":"PMC_25444159","title":"Direct regulation of diurnal Drd3 expression and cocaine reward by NPAS2.","date":"2014","source":"Biological psychiatry","url":"https://pubmed.ncbi.nlm.nih.gov/25444159","citation_count":74,"is_preprint":false},{"pmid":"9491816","id":"PMC_9491816","title":"The dopamine D3 receptor (DRD3) Ser9Gly polymorphism and schizophrenia: a haplotype relative risk study and association with clozapine response.","date":"1998","source":"Molecular psychiatry","url":"https://pubmed.ncbi.nlm.nih.gov/9491816","citation_count":74,"is_preprint":false},{"pmid":"9514583","id":"PMC_9514583","title":"European Multicentre Association Study of Schizophrenia: a study of the DRD2 Ser311Cys and DRD3 Ser9Gly polymorphisms.","date":"1998","source":"American journal of medical genetics","url":"https://pubmed.ncbi.nlm.nih.gov/9514583","citation_count":72,"is_preprint":false},{"pmid":"10686561","id":"PMC_10686561","title":"COMT and DRD3 polymorphisms, environmental exposures, and personality traits related to common mental disorders.","date":"2000","source":"American journal of medical genetics","url":"https://pubmed.ncbi.nlm.nih.gov/10686561","citation_count":69,"is_preprint":false},{"pmid":"19058789","id":"PMC_19058789","title":"A common variant in DRD3 receptor is associated with autism spectrum disorder.","date":"2008","source":"Biological psychiatry","url":"https://pubmed.ncbi.nlm.nih.gov/19058789","citation_count":65,"is_preprint":false},{"pmid":"9790747","id":"PMC_9790747","title":"Population studies of polymorphisms at loci of neuropsychiatric interest (tryptophan hydroxylase (TPH), dopamine transporter protein (SLC6A3), D3 dopamine receptor (DRD3), apolipoprotein E (APOE), mu opioid receptor (OPRM1), and ciliary neurotrophic factor (CNTF)).","date":"1998","source":"Genomics","url":"https://pubmed.ncbi.nlm.nih.gov/9790747","citation_count":63,"is_preprint":false},{"pmid":"34048697","id":"PMC_34048697","title":"Ventral pallidum DRD3 potentiates a pallido-habenular circuit driving accumbal dopamine release and cocaine seeking.","date":"2021","source":"Neuron","url":"https://pubmed.ncbi.nlm.nih.gov/34048697","citation_count":63,"is_preprint":false},{"pmid":"9154247","id":"PMC_9154247","title":"DRD2, DRD3 and 5HT2A receptor genes polymorphisms in obsessive-compulsive disorder.","date":"1996","source":"Molecular psychiatry","url":"https://pubmed.ncbi.nlm.nih.gov/9154247","citation_count":63,"is_preprint":false},{"pmid":"8950413","id":"PMC_8950413","title":"Association study of bipolar disorder with candidate genes involved in catecholamine neurotransmission: DRD2, DRD3, DAT1, and TH genes.","date":"1996","source":"American journal of medical genetics","url":"https://pubmed.ncbi.nlm.nih.gov/8950413","citation_count":58,"is_preprint":false},{"pmid":"10893495","id":"PMC_10893495","title":"Association of dopamine D3-receptor gene variants with neuroleptic induced akathisia in schizophrenic patients: a generalization of Steen's study on DRD3 and tardive dyskinesia.","date":"2000","source":"American journal of medical genetics","url":"https://pubmed.ncbi.nlm.nih.gov/10893495","citation_count":57,"is_preprint":false},{"pmid":"23365649","id":"PMC_23365649","title":"The functional DRD3 Ser9Gly polymorphism (rs6280) is pleiotropic, affecting reward as well as movement.","date":"2013","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/23365649","citation_count":55,"is_preprint":false},{"pmid":"19396436","id":"PMC_19396436","title":"Association of the DRD2 and DRD3 polymorphisms with response to pramipexole in Parkinson's disease patients.","date":"2009","source":"European journal of clinical pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/19396436","citation_count":51,"is_preprint":false},{"pmid":"21691864","id":"PMC_21691864","title":"Brief report: the dopamine-3-receptor gene (DRD3) is associated with specific repetitive behavior in autism spectrum disorder (ASD).","date":"2012","source":"Journal of autism and developmental disorders","url":"https://pubmed.ncbi.nlm.nih.gov/21691864","citation_count":50,"is_preprint":false},{"pmid":"17407504","id":"PMC_17407504","title":"Dopamine receptor genes (DRD2, DRD3 and DRD4) and gene-gene interactions associated with smoking-related behaviors.","date":"2007","source":"Addiction biology","url":"https://pubmed.ncbi.nlm.nih.gov/17407504","citation_count":49,"is_preprint":false},{"pmid":"10697826","id":"PMC_10697826","title":"Association between the dopamine D3 receptor gene locus (DRD3) and unipolar affective disorder.","date":"1999","source":"Psychiatric genetics","url":"https://pubmed.ncbi.nlm.nih.gov/10697826","citation_count":49,"is_preprint":false},{"pmid":"21663922","id":"PMC_21663922","title":"Association of DRD2 and DRD3 polymorphisms with Parkinson's disease in a multiethnic consortium.","date":"2011","source":"Journal of the neurological sciences","url":"https://pubmed.ncbi.nlm.nih.gov/21663922","citation_count":47,"is_preprint":false},{"pmid":"11673801","id":"PMC_11673801","title":"Dopamine D3 receptor (DRD3) gene polymorphism is associated with the intensity of eye movement disturbances in schizophrenic patients and healthy subjects.","date":"2001","source":"Molecular psychiatry","url":"https://pubmed.ncbi.nlm.nih.gov/11673801","citation_count":47,"is_preprint":false},{"pmid":"7860086","id":"PMC_7860086","title":"An association study between schizophrenia and the dopamine receptor genes DRD3 and DRD4 using haplotype relative risk.","date":"1994","source":"Human heredity","url":"https://pubmed.ncbi.nlm.nih.gov/7860086","citation_count":47,"is_preprint":false},{"pmid":"9017973","id":"PMC_9017973","title":"Evidence for an association between the dopamine D3 receptor gene DRD3 and schizophrenia.","date":"1997","source":"Human heredity","url":"https://pubmed.ncbi.nlm.nih.gov/9017973","citation_count":47,"is_preprint":false},{"pmid":"12860355","id":"PMC_12860355","title":"Polymorphisms of DRD4 and DRD3 and risk of avoidant and obsessive personality traits and disorders.","date":"2003","source":"Psychiatry research","url":"https://pubmed.ncbi.nlm.nih.gov/12860355","citation_count":46,"is_preprint":false},{"pmid":"19439249","id":"PMC_19439249","title":"Tardive dyskinesia and DRD3, HTR2A and HTR2C gene polymorphisms in Russian psychiatric inpatients from Siberia.","date":"2009","source":"Progress in neuro-psychopharmacology & biological psychiatry","url":"https://pubmed.ncbi.nlm.nih.gov/19439249","citation_count":45,"is_preprint":false},{"pmid":"18348205","id":"PMC_18348205","title":"A functional polymorphism, rs6280, in DRD3 is significantly associated with nicotine dependence in European-American smokers.","date":"2008","source":"American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics","url":"https://pubmed.ncbi.nlm.nih.gov/18348205","citation_count":44,"is_preprint":false},{"pmid":"16395310","id":"PMC_16395310","title":"A Ser9Gly polymorphism in the dopamine D3 receptor gene (DRD3) and event-related P300 potentials.","date":"2006","source":"Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/16395310","citation_count":44,"is_preprint":false},{"pmid":"11104840","id":"PMC_11104840","title":"DRD3 and DAT1 genes in schizophrenia: an association study.","date":"2000","source":"Journal of psychiatric research","url":"https://pubmed.ncbi.nlm.nih.gov/11104840","citation_count":43,"is_preprint":false},{"pmid":"10523822","id":"PMC_10523822","title":"Homozygosity at the dopamine DRD3 receptor gene in cocaine dependence.","date":"1999","source":"Molecular psychiatry","url":"https://pubmed.ncbi.nlm.nih.gov/10523822","citation_count":43,"is_preprint":false},{"pmid":"35896696","id":"PMC_35896696","title":"Pramipexole inhibits astrocytic NLRP3 inflammasome activation via Drd3-dependent autophagy in a mouse model of Parkinson's disease.","date":"2022","source":"Acta pharmacologica Sinica","url":"https://pubmed.ncbi.nlm.nih.gov/35896696","citation_count":42,"is_preprint":false},{"pmid":"19897343","id":"PMC_19897343","title":"The dopamine D3 receptor (DRD3) gene and risk of schizophrenia: case-control studies and an updated meta-analysis.","date":"2010","source":"Schizophrenia research","url":"https://pubmed.ncbi.nlm.nih.gov/19897343","citation_count":38,"is_preprint":false},{"pmid":"10889555","id":"PMC_10889555","title":"Mutation and association analysis of the 5' region of the dopamine D3 receptor gene in schizophrenia patients: identification of the Ala38Thr polymorphism and suggested association between DRD3 haplotypes and schizophrenia.","date":"2000","source":"Molecular psychiatry","url":"https://pubmed.ncbi.nlm.nih.gov/10889555","citation_count":38,"is_preprint":false},{"pmid":"10670776","id":"PMC_10670776","title":"A cluster of single nucleotide polymorphisms in the 5'-leader of the human dopamine D3 receptor gene (DRD3) and its relationship to schizophrenia.","date":"2000","source":"Neuroscience letters","url":"https://pubmed.ncbi.nlm.nih.gov/10670776","citation_count":38,"is_preprint":false},{"pmid":"19766158","id":"PMC_19766158","title":"Genetic polymorphisms in the dopamine-2 receptor (DRD2), dopamine-3 receptor (DRD3), and dopamine transporter (SLC6A3) genes in schizophrenia: Data from an association study.","date":"2009","source":"Progress in neuro-psychopharmacology & biological psychiatry","url":"https://pubmed.ncbi.nlm.nih.gov/19766158","citation_count":37,"is_preprint":false},{"pmid":"15371743","id":"PMC_15371743","title":"Role of DRD3 in morphine-induced conditioned place preference using drd3-knockout mice.","date":"2004","source":"Neuroreport","url":"https://pubmed.ncbi.nlm.nih.gov/15371743","citation_count":37,"is_preprint":false},{"pmid":"17924589","id":"PMC_17924589","title":"Could HTR2A T102C and DRD3 Ser9Gly predict clinical improvement in patients with acutely exacerbated schizophrenia? Results from treatment responses to risperidone in a naturalistic setting.","date":"2008","source":"Human psychopharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/17924589","citation_count":37,"is_preprint":false},{"pmid":"25224105","id":"PMC_25224105","title":"Autism, DRD3 and repetitive and stereotyped behavior, an overview of the current knowledge.","date":"2014","source":"European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/25224105","citation_count":36,"is_preprint":false},{"pmid":"19506579","id":"PMC_19506579","title":"A common variant in DRD3 gene is associated with risperidone-induced extrapyramidal symptoms.","date":"2009","source":"The pharmacogenomics journal","url":"https://pubmed.ncbi.nlm.nih.gov/19506579","citation_count":36,"is_preprint":false},{"pmid":"19217756","id":"PMC_19217756","title":"Genetic study of BDNF, DRD3, and their interaction in tardive dyskinesia.","date":"2009","source":"European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/19217756","citation_count":35,"is_preprint":false},{"pmid":"22940547","id":"PMC_22940547","title":"Preliminary evidence for association between schizophrenia and polymorphisms in the regulatory Regions of the ADRA2A, DRD3 and SNAP-25 Genes.","date":"2012","source":"Psychiatry research","url":"https://pubmed.ncbi.nlm.nih.gov/22940547","citation_count":35,"is_preprint":false},{"pmid":"17429404","id":"PMC_17429404","title":"Effects of the dopamine D3 receptor (DRD3) gene polymorphisms on risperidone response: a pharmacogenetic study.","date":"2007","source":"Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/17429404","citation_count":30,"is_preprint":false},{"pmid":"24398431","id":"PMC_24398431","title":"DRD3 variation associates with early-onset heroin dependence, but not specific personality traits.","date":"2014","source":"Progress in neuro-psychopharmacology & biological psychiatry","url":"https://pubmed.ncbi.nlm.nih.gov/24398431","citation_count":30,"is_preprint":false},{"pmid":"31538542","id":"PMC_31538542","title":"DRD3 (dopamine receptor D3) but not DRD2 activates autophagy through MTORC1 inhibition preserving protein synthesis.","date":"2019","source":"Autophagy","url":"https://pubmed.ncbi.nlm.nih.gov/31538542","citation_count":28,"is_preprint":false},{"pmid":"24021960","id":"PMC_24021960","title":"Genetic variants of the BDNF and DRD3 genes in bipolar disorder comorbid with anxiety disorder.","date":"2013","source":"Journal of affective disorders","url":"https://pubmed.ncbi.nlm.nih.gov/24021960","citation_count":28,"is_preprint":false},{"pmid":"9149327","id":"PMC_9149327","title":"No association between particular DRD3 and DAT gene polymorphisms and manic-depressive illness in a Spanish sample.","date":"1996","source":"Psychiatric genetics","url":"https://pubmed.ncbi.nlm.nih.gov/9149327","citation_count":28,"is_preprint":false},{"pmid":"12893467","id":"PMC_12893467","title":"No association between D3 dopamine receptor (DRD3) alleles and cocaine dependence.","date":"1996","source":"Addiction biology","url":"https://pubmed.ncbi.nlm.nih.gov/12893467","citation_count":27,"is_preprint":false},{"pmid":"18316228","id":"PMC_18316228","title":"Reappraisal of the role of the DRD3 gene in essential tremor.","date":"2008","source":"Parkinsonism & related disorders","url":"https://pubmed.ncbi.nlm.nih.gov/18316228","citation_count":27,"is_preprint":false},{"pmid":"9577839","id":"PMC_9577839","title":"Examination of new and reported data of the DRD3/MscI polymorphism: no support for the proposed association with schizophrenia.","date":"1998","source":"Molecular psychiatry","url":"https://pubmed.ncbi.nlm.nih.gov/9577839","citation_count":27,"is_preprint":false},{"pmid":"20698735","id":"PMC_20698735","title":"The COMT and DRD3 genes interacted in bipolar I but not bipolar II disorder.","date":"2010","source":"The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry","url":"https://pubmed.ncbi.nlm.nih.gov/20698735","citation_count":27,"is_preprint":false},{"pmid":"17125970","id":"PMC_17125970","title":"Extensive linkage disequilibrium mapping at HTR2A and DRD3 for schizophrenia susceptibility genes in the Galician population.","date":"2006","source":"Schizophrenia research","url":"https://pubmed.ncbi.nlm.nih.gov/17125970","citation_count":27,"is_preprint":false},{"pmid":"19358223","id":"PMC_19358223","title":"The DRD3 rs6280 polymorphism and prevalence of tardive dyskinesia: a meta-analysis.","date":"2010","source":"American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics","url":"https://pubmed.ncbi.nlm.nih.gov/19358223","citation_count":26,"is_preprint":false},{"pmid":"25792691","id":"PMC_25792691","title":"DRD3 gene and striatum in autism spectrum disorder.","date":"2015","source":"The British journal of psychiatry : the journal of mental science","url":"https://pubmed.ncbi.nlm.nih.gov/25792691","citation_count":26,"is_preprint":false},{"pmid":"19309018","id":"PMC_19309018","title":"Genetic polymorphisms in the DRD2, DRD3, and SLC6A3 gene in elderly patients with delirium.","date":"2010","source":"American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics","url":"https://pubmed.ncbi.nlm.nih.gov/19309018","citation_count":26,"is_preprint":false},{"pmid":"24649110","id":"PMC_24649110","title":"Polymorphisms of DRD2 and DRD3 genes and Parkinson's disease: A meta-analysis.","date":"2014","source":"Biomedical reports","url":"https://pubmed.ncbi.nlm.nih.gov/24649110","citation_count":25,"is_preprint":false},{"pmid":"15342129","id":"PMC_15342129","title":"Psychotic symptoms in Alzheimer's disease are not influenced by polymorphic variation at the dopamine receptor DRD3 gene.","date":"2004","source":"Neuroscience letters","url":"https://pubmed.ncbi.nlm.nih.gov/15342129","citation_count":25,"is_preprint":false},{"pmid":"18472202","id":"PMC_18472202","title":"The association of genotypic combination of the DRD3 and BDNF polymorphisms on the adhesio interthalamica and medial temporal lobe structures.","date":"2008","source":"Progress in neuro-psychopharmacology & biological psychiatry","url":"https://pubmed.ncbi.nlm.nih.gov/18472202","citation_count":24,"is_preprint":false},{"pmid":"25927430","id":"PMC_25927430","title":"Association of DRD3, COMT, and SLC6A4 Gene Polymorphisms with Type 2 Diabetes in Southern Chinese: A Hospital-Based Case-Control Study.","date":"2015","source":"Diabetes technology & therapeutics","url":"https://pubmed.ncbi.nlm.nih.gov/25927430","citation_count":23,"is_preprint":false},{"pmid":"19353703","id":"PMC_19353703","title":"Motor complications in patients form the German Competence Network on Parkinson's disease and the DRD3 Ser9Gly polymorphism.","date":"2009","source":"Movement disorders : official journal of the Movement Disorder Society","url":"https://pubmed.ncbi.nlm.nih.gov/19353703","citation_count":23,"is_preprint":false},{"pmid":"26857559","id":"PMC_26857559","title":"A pharmacogenetic pilot study reveals MTHFR, DRD3, and MDR1 polymorphisms as biomarker candidates for slow atorvastatin metabolizers.","date":"2016","source":"BMC cancer","url":"https://pubmed.ncbi.nlm.nih.gov/26857559","citation_count":23,"is_preprint":false},{"pmid":"18449897","id":"PMC_18449897","title":"Lack of association between DRD3 gene polymorphism and response to clozapine in Turkish schizoprenia patients.","date":"2009","source":"American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics","url":"https://pubmed.ncbi.nlm.nih.gov/18449897","citation_count":22,"is_preprint":false},{"pmid":"18484990","id":"PMC_18484990","title":"DRD3 Ser9Gly variant is not associated with essential tremor in a series of Italian patients.","date":"2008","source":"European journal of neurology","url":"https://pubmed.ncbi.nlm.nih.gov/18484990","citation_count":22,"is_preprint":false},{"pmid":"19645064","id":"PMC_19645064","title":"Dopamine receptor D3 (DRD3) genotype and allelic variants and risk for essential tremor.","date":"2009","source":"Movement disorders : official journal of the Movement Disorder Society","url":"https://pubmed.ncbi.nlm.nih.gov/19645064","citation_count":21,"is_preprint":false},{"pmid":"15083167","id":"PMC_15083167","title":"Association between schizophrenia and DRD3 or HTR2 receptor gene variants.","date":"2004","source":"European journal of human genetics : EJHG","url":"https://pubmed.ncbi.nlm.nih.gov/15083167","citation_count":21,"is_preprint":false},{"pmid":"27779245","id":"PMC_27779245","title":"Association between DRD2 and DRD3 gene polymorphisms and gastrointestinal symptoms induced by levodopa therapy in Parkinson's disease.","date":"2016","source":"The pharmacogenomics journal","url":"https://pubmed.ncbi.nlm.nih.gov/27779245","citation_count":20,"is_preprint":false},{"pmid":"29361389","id":"PMC_29361389","title":"Behavioral addictions in early-onset Parkinson disease are associated with DRD3 variants.","date":"2018","source":"Parkinsonism & related disorders","url":"https://pubmed.ncbi.nlm.nih.gov/29361389","citation_count":20,"is_preprint":false},{"pmid":"17698325","id":"PMC_17698325","title":"No association between the DRD3 Ser9Gly polymorphism and schizophrenia.","date":"2007","source":"Schizophrenia research","url":"https://pubmed.ncbi.nlm.nih.gov/17698325","citation_count":20,"is_preprint":false},{"pmid":"11378841","id":"PMC_11378841","title":"Allelic variation of a BalI polymorphism in the DRD3 gene does not influence susceptibility to bipolar disorder: results of analysis and meta-analysis.","date":"2001","source":"American journal of medical genetics","url":"https://pubmed.ncbi.nlm.nih.gov/11378841","citation_count":20,"is_preprint":false},{"pmid":"31143436","id":"PMC_31143436","title":"The Association between DRD3 Ser9Gly Polymorphism and Depression Severity in Parkinson's Disease.","date":"2019","source":"Parkinson's disease","url":"https://pubmed.ncbi.nlm.nih.gov/31143436","citation_count":19,"is_preprint":false},{"pmid":"25262640","id":"PMC_25262640","title":"Significant association between DRD3 gene body methylation and schizophrenia.","date":"2014","source":"Psychiatry research","url":"https://pubmed.ncbi.nlm.nih.gov/25262640","citation_count":19,"is_preprint":false},{"pmid":"30464483","id":"PMC_30464483","title":"Association study between COMT, DRD2, and DRD3 gene variants and antipsychotic treatment response in Mexican patients with schizophrenia.","date":"2018","source":"Neuropsychiatric disease and treatment","url":"https://pubmed.ncbi.nlm.nih.gov/30464483","citation_count":19,"is_preprint":false},{"pmid":"16759339","id":"PMC_16759339","title":"No association of dopamine receptor sensitivity in vivo with genetic predisposition for alcoholism and DRD2/DRD3 gene polymorphisms in alcohol dependence.","date":"2006","source":"Addiction biology","url":"https://pubmed.ncbi.nlm.nih.gov/16759339","citation_count":19,"is_preprint":false},{"pmid":"16524466","id":"PMC_16524466","title":"Cognitive dysfunction in NF1 knock-out mice may result from altered vesicular trafficking of APP/DRD3 complex.","date":"2006","source":"BMC neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/16524466","citation_count":19,"is_preprint":false},{"pmid":"26627941","id":"PMC_26627941","title":"Association of Parkinson disease age of onset with DRD2, DRD3 and GRIN2B polymorphisms.","date":"2015","source":"Parkinsonism & related disorders","url":"https://pubmed.ncbi.nlm.nih.gov/26627941","citation_count":18,"is_preprint":false},{"pmid":"20667458","id":"PMC_20667458","title":"Association study of BDNF and DRD3 genes in schizophrenia diagnosis using matched case-control and family based study designs.","date":"2010","source":"Progress in neuro-psychopharmacology & biological psychiatry","url":"https://pubmed.ncbi.nlm.nih.gov/20667458","citation_count":17,"is_preprint":false},{"pmid":"24776816","id":"PMC_24776816","title":"DRD3 gene rs6280 polymorphism may be associated with alcohol dependence overall and with Lesch type I alcohol dependence in Koreans.","date":"2014","source":"Neuropsychobiology","url":"https://pubmed.ncbi.nlm.nih.gov/24776816","citation_count":16,"is_preprint":false},{"pmid":"18987889","id":"PMC_18987889","title":"A common haplotype of DRD3 affected by recent positive selection is associated with protection from schizophrenia.","date":"2008","source":"Human genetics","url":"https://pubmed.ncbi.nlm.nih.gov/18987889","citation_count":16,"is_preprint":false},{"pmid":"19302829","id":"PMC_19302829","title":"Effects of the DRD3 Ser9Gly polymorphism on aripiprazole efficacy in schizophrenic patients as modified by clinical factors.","date":"2009","source":"Progress in neuro-psychopharmacology & biological psychiatry","url":"https://pubmed.ncbi.nlm.nih.gov/19302829","citation_count":16,"is_preprint":false},{"pmid":"30051166","id":"PMC_30051166","title":"DRD3 Gene and ADHD: A Pharmaco-Behavioural Genetic Study.","date":"2018","source":"Neuromolecular medicine","url":"https://pubmed.ncbi.nlm.nih.gov/30051166","citation_count":14,"is_preprint":false},{"pmid":"19524641","id":"PMC_19524641","title":"DRD3 Ser9Gly and HS1BP3 Ala265Gly are not associated with Parkinson disease.","date":"2009","source":"Neuroscience letters","url":"https://pubmed.ncbi.nlm.nih.gov/19524641","citation_count":14,"is_preprint":false},{"pmid":"29249220","id":"PMC_29249220","title":"DRD3 Ser9Gly Polymorphism and Its Influence on Risperidone Response in Autistic Children.","date":"2017","source":"Journal of pharmacy & pharmaceutical sciences : a publication of the Canadian Society for Pharmaceutical Sciences, Societe canadienne des sciences pharmaceutiques","url":"https://pubmed.ncbi.nlm.nih.gov/29249220","citation_count":14,"is_preprint":false},{"pmid":"27817855","id":"PMC_27817855","title":"Association of the DRD2 CAn-STR and DRD3 Ser9Gly polymorphisms with Parkinson's disease and response to dopamine agonists.","date":"2016","source":"Journal of the neurological sciences","url":"https://pubmed.ncbi.nlm.nih.gov/27817855","citation_count":14,"is_preprint":false},{"pmid":"26376054","id":"PMC_26376054","title":"Epistasis between COMT Val158Met and DRD3 Ser9Gly polymorphisms and cognitive function in schizophrenia: genetic influence on dopamine transmission.","date":"2015","source":"Revista brasileira de psiquiatria (Sao Paulo, Brazil : 1999)","url":"https://pubmed.ncbi.nlm.nih.gov/26376054","citation_count":14,"is_preprint":false},{"pmid":"29791666","id":"PMC_29791666","title":"Prevalence of polymorphisms in the ANKK1, DRD2, DRD3 genes and metabolic syndrome in refractory schizophrenia.","date":"2018","source":"Revista latino-americana de enfermagem","url":"https://pubmed.ncbi.nlm.nih.gov/29791666","citation_count":14,"is_preprint":false},{"pmid":"20236178","id":"PMC_20236178","title":"Dopamine receptor 3 (DRD3) polymorphism and risk for migraine.","date":"2010","source":"European journal of neurology","url":"https://pubmed.ncbi.nlm.nih.gov/20236178","citation_count":12,"is_preprint":false},{"pmid":"31798476","id":"PMC_31798476","title":"Association of rs4680 COMT, rs6280 DRD3, and rs7322347 5HT2A With Clinical Features of Youth-Onset Schizophrenia.","date":"2019","source":"Frontiers in psychiatry","url":"https://pubmed.ncbi.nlm.nih.gov/31798476","citation_count":12,"is_preprint":false},{"pmid":"25264289","id":"PMC_25264289","title":"Investigation of the genetic interaction between BDNF and DRD3 genes in suicidical behaviour in psychiatric disorders.","date":"2014","source":"The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry","url":"https://pubmed.ncbi.nlm.nih.gov/25264289","citation_count":12,"is_preprint":false},{"pmid":"22877924","id":"PMC_22877924","title":"Interaction of the DRD3 and BDNF gene variants in subtyped bipolar disorder.","date":"2012","source":"Progress in neuro-psychopharmacology & biological psychiatry","url":"https://pubmed.ncbi.nlm.nih.gov/22877924","citation_count":11,"is_preprint":false},{"pmid":"29357295","id":"PMC_29357295","title":"Association study of BDNF and DRD3 genes with alcohol use disorder in Schizophrenia.","date":"2018","source":"Neuroscience letters","url":"https://pubmed.ncbi.nlm.nih.gov/29357295","citation_count":11,"is_preprint":false},{"pmid":"17018139","id":"PMC_17018139","title":"No association of DRD2, DRD3, and tyrosine hydroxylase gene polymorphisms with personality traits in the Japanese population.","date":"2006","source":"Behavioral and brain functions : BBF","url":"https://pubmed.ncbi.nlm.nih.gov/17018139","citation_count":11,"is_preprint":false},{"pmid":"15051179","id":"PMC_15051179","title":"Family association study between DRD2 and DRD3 gene polymorphisms and schizophrenia in a Portuguese population.","date":"2004","source":"Psychiatry research","url":"https://pubmed.ncbi.nlm.nih.gov/15051179","citation_count":11,"is_preprint":false},{"pmid":"27665700","id":"PMC_27665700","title":"Gene-gene interactions between DRD3, MRP4 and CYP2B6 polymorphisms and its influence on the pharmacokinetic parameters of efavirenz in HIV infected patients.","date":"2016","source":"Drug metabolism and pharmacokinetics","url":"https://pubmed.ncbi.nlm.nih.gov/27665700","citation_count":10,"is_preprint":false},{"pmid":"30005280","id":"PMC_30005280","title":"Differential effect of the DRD3 genotype on inflammatory cytokine responses during abstinence in amphetamine-dependent women.","date":"2018","source":"Psychoneuroendocrinology","url":"https://pubmed.ncbi.nlm.nih.gov/30005280","citation_count":9,"is_preprint":false},{"pmid":"20672519","id":"PMC_20672519","title":"[Family based association study of DRD1, DRD2, DRD3, DRD4, DAT, COMT gene polymorphism in schizophrenia].","date":"2010","source":"Psychiatria polska","url":"https://pubmed.ncbi.nlm.nih.gov/20672519","citation_count":9,"is_preprint":false},{"pmid":"26787837","id":"PMC_26787837","title":"A GIPC1-Palmitate Switch Modulates Dopamine Drd3 Receptor Trafficking and Signaling.","date":"2016","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/26787837","citation_count":8,"is_preprint":false},{"pmid":"27909828","id":"PMC_27909828","title":"The dopamine-related polymorphisms BDNF, COMT, DRD2, DRD3, and DRD4 are not linked with changes in CSF dopamine levels and frequency of HIV infection.","date":"2016","source":"Journal of neural transmission (Vienna, Austria : 1996)","url":"https://pubmed.ncbi.nlm.nih.gov/27909828","citation_count":8,"is_preprint":false},{"pmid":"35455685","id":"PMC_35455685","title":"Dopamine DRD2 and DRD3 Polymorphisms Involvement in Nicotine Dependence in Patients with Treatment-Resistant Mental Disorders.","date":"2022","source":"Journal of personalized medicine","url":"https://pubmed.ncbi.nlm.nih.gov/35455685","citation_count":7,"is_preprint":false},{"pmid":"24927283","id":"PMC_24927283","title":"Role of nicotine dependence in the association between the dopamine receptor gene DRD3 and major depressive disorder.","date":"2014","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/24927283","citation_count":7,"is_preprint":false}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":50323,"output_tokens":2268,"usd":0.092494,"stage1_stop_reason":"end_turn"},"stage2":{"model":"claude-opus-4-8","input_tokens":9363,"output_tokens":3151,"usd":0.062795,"stage2_stop_reason":"end_turn"},"total_usd":0.155289,"stage1_batch_id":"msgbatch_01AsR7g8dGTEiEw9U83bJeWn","stage2_batch_id":"msgbatch_01YV5ZyxtFNUZEjxRcpd9jzb","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 2017,\n      \"finding\": \"Drd3 signaling in lateral septum (LS) neurons is necessary and sufficient for normal social behavior; ELS-induced downregulation of Drd3 blunts activity of Drd3-expressing LS neurons in response to social stimuli, and optogenetic activation of Drd3LS neurons or pharmacological Drd3 agonism rescues ELS-induced social impairments.\",\n      \"method\": \"In vivo Ca2+ imaging, optogenetics, pharmacological agonism, viral-mediated knockdown, behavioral assays in mice\",\n      \"journal\": \"Neuron\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — multiple orthogonal methods (in vivo imaging, optogenetics, pharmacology, KD) in a single rigorous study with defined cellular and behavioral phenotypes\",\n      \"pmids\": [\"29276054\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"DRD3-dependent plasticity in the ventral pallidum (VP) drives potentiation of nucleus accumbens dopamine release during relapse to cocaine seeking; two distinct VP DRD3+ neuronal populations project to lateral habenula (LHb) or VTA with different activity patterns during drug seeking, and selective suppression of LHb-projecting population activity or DRD3 signaling reduces cocaine seeking.\",\n      \"method\": \"Circuit-specific optogenetics, DRD3 signaling suppression, dopamine release measurements, cocaine self-administration/relapse paradigm in mice\",\n      \"journal\": \"Neuron\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — multiple orthogonal circuit-dissection methods with defined behavioral and neurochemical readouts in a single rigorous study\",\n      \"pmids\": [\"34048697\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"NPAS2, a circadian transcription factor, directly binds the Drd3 promoter and drives its diurnal rhythmic expression in nucleus accumbens D1-expressing neurons; Npas2 knockdown in NAc disrupts Drd3 diurnal rhythm and decreases cocaine reward, whereas CLOCK knockdown has no effect.\",\n      \"method\": \"Chromatin immunoprecipitation followed by deep sequencing (ChIP-seq), AAV-shRNA knockdown in NAc, conditioned place preference assay, cell-sorting qRT-PCR\",\n      \"journal\": \"Biological psychiatry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — ChIP-seq identifies direct binding site, complemented by in vivo knockdown with behavioral and molecular readouts, single lab but multiple orthogonal methods\",\n      \"pmids\": [\"25444159\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"DRD3 (but not DRD2) activates autophagy through an AMPK → inhibitory phosphorylation of RPTOR → MTORC1 inhibition → ULK1 activation pathway; despite MTORC1 inhibition, DRD3 preserves protein synthesis via the MAPK1/3–RPS6KA pathway, distinguishing it from direct mTOR inhibitors.\",\n      \"method\": \"DRD3/DRD2-overexpressing cells, drd3 KO and drd2 KO mice, pramipexole treatment, Western blot for autophagy/mTOR pathway components, GFP-LC3 puncta assay\",\n      \"journal\": \"Autophagy\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 / Strong — genetic KO models plus receptor-overexpression, in vitro and in vivo concordance, multiple pathway readouts; single lab but rigorous mechanistic dissection\",\n      \"pmids\": [\"31538542\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"PPX (pramipexole) suppresses NLRP3 inflammasome activation in astrocytes via a Drd3-dependent enhancement of autophagy; Drd3 depletion abolishes PPX-induced autophagy and NLRP3 suppression, and astrocyte-specific Atg5 knockdown blocks PPX neuroprotection in a mouse PD model.\",\n      \"method\": \"Drd3 siRNA depletion in primary astrocytes, LPS/ATP inflammasome stimulation, LC3-II/BECN1 western blot, GFP-LC3 puncta, astrocyte-specific Atg5 knockdown in vivo, LPS PD mouse model\",\n      \"journal\": \"Acta pharmacologica Sinica\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — genetic loss-of-function (siRNA and in vivo Atg5 KD) with concordant in vitro and in vivo readouts, multiple orthogonal approaches, single lab\",\n      \"pmids\": [\"35896696\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"DRD3 palmitoylation acts as a molecular switch for biased signaling: palmitoylation of the Drd3 C-terminal cytoplasmic domain exposes a docking site for the scaffold protein GIPC1, redirecting receptor trafficking and signaling; disruption of palmitoylation or GIPC1 interaction alters Drd3 internalization and downstream signaling.\",\n      \"method\": \"Molecular dynamics simulation, Co-IP/biochemical interaction studies, live-cell imaging, site-directed mutagenesis of palmitoylation/GIPC1-binding sites in cultured cells\",\n      \"journal\": \"Molecular and cellular biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — combines computational modeling with biochemical pulldown, live imaging, and mutagenesis; single lab, mechanistic but abstract-level detail limits full Tier 1 assignment\",\n      \"pmids\": [\"26787837\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"DRD3 mediates expression of conditioned rewarding effects of morphine: in drd3 knockout mice, morphine conditioned place preference (CPP) is retained but the DRD3-selective partial agonist BP897 fails to inhibit CPP expression, and BP897 reduces c-fos activation in somatosensory cortex only in wild-type mice.\",\n      \"method\": \"drd3 knockout mice, conditioned place preference, c-fos imaging, pharmacological intervention with BP897\",\n      \"journal\": \"Neuroreport\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — clean genetic KO with pharmacological probe and brain imaging readout; single lab, moderate method breadth\",\n      \"pmids\": [\"15371743\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"The DRD3 Ser9Gly (Gly allele) functional missense variant is associated with greater reward-related striatal dopamine release (measured as increased displacement of [11C]raclopride) during unpredictable monetary reward in the anterior caudate and ventral striatum, consistent with Gly-form D3 autoreceptors having higher DA affinity and more robust intracellular signaling.\",\n      \"method\": \"PET with [11C]raclopride bolus-plus-infusion in humans during gambling vs. sensorimotor task, linear regression controlling for age, sex, diagnosis\",\n      \"journal\": \"PloS one\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Weak — direct in vivo DA release measurement in humans with genotype stratification; single lab, single method, modest sample size (n=36)\",\n      \"pmids\": [\"23365649\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"DRD3 is a G protein-coupled dopamine receptor that (1) in the lateral septum mediates social behavior downstream of early-life stress by modulating neuronal activity; (2) in the ventral pallidum drives a pallido-habenular circuit potentiating accumbal dopamine release during cocaine relapse; (3) in the nucleus accumbens is a direct transcriptional target of the circadian factor NPAS2, coupling circadian rhythms to reward signaling; (4) activates autophagy via AMPK–MTORC1–ULK1 signaling while preserving protein synthesis through the MAPK/RPS6KA axis; (5) in astrocytes suppresses NLRP3 inflammasome activity through Drd3-dependent autophagy induction; and (6) undergoes palmitoylation that acts as a molecular switch recruiting GIPC1 to redirect receptor trafficking and biased signaling.\"\n}\n```","stage2_raw":"{\n  \"mechanistic_narrative\": \"DRD3 is a G protein-coupled dopamine receptor that shapes reward, social behavior, and dopaminergic circuit plasticity while also coupling receptor signaling to autophagy and inflammasome control [#0, #3]. In the brain, Drd3 in lateral septum neurons is necessary and sufficient for normal social behavior, and its early-life-stress-induced downregulation blunts social-stimulus-evoked neuronal activity that optogenetic or pharmacological reactivation rescues [#0]. Within reward circuitry, DRD3-dependent plasticity in the ventral pallidum drives a pallido-habenular projection that potentiates accumbal dopamine release during cocaine relapse [#1], and Drd3 reward function is gated transcriptionally and temporally by the circadian factor NPAS2, which binds the Drd3 promoter to impose diurnal expression in nucleus accumbens D1 neurons [#2]. At the signaling level, DRD3 — but not DRD2 — activates autophagy through an AMPK\\u2192RPTOR\\u2192MTORC1 inhibition\\u2192ULK1 cascade while preserving protein synthesis via the MAPK1/3\\u2013RPS6KA axis [#3], and this Drd3-dependent autophagy suppresses NLRP3 inflammasome activation in astrocytes to confer neuroprotection [#4]. Receptor trafficking and biased signaling are controlled by palmitoylation of the DRD3 C-terminal cytoplasmic domain, which exposes a docking site for the scaffold GIPC1 to redirect internalization [#5].\",\n  \"teleology\": [\n    {\n      \"year\": 2004,\n      \"claim\": \"Established that DRD3 is required for the pharmacological modulation of morphine reward expression, linking the receptor to drug-conditioned behavior.\",\n      \"evidence\": \"drd3 knockout mice with morphine conditioned place preference, c-fos imaging, and BP897 pharmacology\",\n      \"pmids\": [\"15371743\"],\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"\",\n      \"gaps\": [\n        \"Does not define the circuit or cellular site of DRD3 action in reward\",\n        \"Mechanism of how BP897 reduces somatosensory c-fos is unresolved\"\n      ]\n    },\n    {\n      \"year\": 2013,\n      \"claim\": \"Showed that a functional human DRD3 coding variant (Ser9Gly) alters reward-related striatal dopamine release, providing in vivo evidence that DRD3 autoreceptor function shapes human reward signaling.\",\n      \"evidence\": \"PET with [11C]raclopride during a reward task with DRD3 genotype stratification in humans\",\n      \"pmids\": [\"23365649\"],\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"\",\n      \"gaps\": [\n        \"Single modest-sample study without independent replication\",\n        \"Does not directly measure receptor affinity or signaling, only inferred from DA displacement\"\n      ]\n    },\n    {\n      \"year\": 2014,\n      \"claim\": \"Identified the transcriptional and temporal control of DRD3 by demonstrating NPAS2 directly drives its diurnal rhythm in accumbal neurons, coupling circadian biology to reward.\",\n      \"evidence\": \"ChIP-seq, AAV-shRNA knockdown in NAc, conditioned place preference, cell-sorting qRT-PCR in mice\",\n      \"pmids\": [\"25444159\"],\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"\",\n      \"gaps\": [\n        \"Does not establish how diurnal Drd3 levels translate to circuit-level reward changes\",\n        \"Distinction from CLOCK control not mechanistically explained\"\n      ]\n    },\n    {\n      \"year\": 2016,\n      \"claim\": \"Defined a post-translational switch for DRD3 signaling, showing that C-terminal palmitoylation recruits GIPC1 to bias receptor trafficking and downstream signaling.\",\n      \"evidence\": \"Molecular dynamics, Co-IP, live-cell imaging, and site-directed mutagenesis in cultured cells\",\n      \"pmids\": [\"26787837\"],\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"\",\n      \"gaps\": [\n        \"Abstract-level mechanistic detail without reconstitution\",\n        \"Identity of the palmitoyl transferase is not defined\",\n        \"Physiological consequence in neurons not tested\"\n      ]\n    },\n    {\n      \"year\": 2017,\n      \"claim\": \"Demonstrated DRD3 is a necessary and sufficient driver of normal social behavior in lateral septum neurons and the molecular target of early-life-stress-induced social deficits.\",\n      \"evidence\": \"In vivo Ca2+ imaging, optogenetics, pharmacology, and viral knockdown in mice\",\n      \"pmids\": [\"29276054\"],\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"\",\n      \"gaps\": [\n        \"Downstream effectors of Drd3LS neuron activity in social behavior unresolved\",\n        \"Molecular mechanism of ELS-induced Drd3 downregulation not defined\"\n      ]\n    },\n    {\n      \"year\": 2019,\n      \"claim\": \"Resolved a DRD3-specific intracellular signaling pathway, showing it activates autophagy via AMPK\\u2192RPTOR\\u2192MTORC1\\u2192ULK1 while uniquely sparing protein synthesis, distinguishing it from DRD2 and direct mTOR inhibitors.\",\n      \"evidence\": \"Receptor-overexpressing cells, drd3 and drd2 KO mice, pramipexole, autophagy/mTOR Western blots and GFP-LC3 assays\",\n      \"pmids\": [\"31538542\"],\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"\",\n      \"gaps\": [\n        \"Proximal G-protein coupling to AMPK activation not mapped\",\n        \"In vivo relevance of preserved protein synthesis not behaviorally tested\"\n      ]\n    },\n    {\n      \"year\": 2021,\n      \"claim\": \"Mapped DRD3 plasticity to a defined ventral pallidum circuit, showing distinct VP DRD3+ populations projecting to LHb or VTA control accumbal dopamine potentiation during cocaine relapse.\",\n      \"evidence\": \"Circuit-specific optogenetics, DRD3 signaling suppression, dopamine release measurements, and cocaine relapse paradigm in mice\",\n      \"pmids\": [\"34048697\"],\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"\",\n      \"gaps\": [\n        \"Molecular nature of DRD3-dependent plasticity in VP not defined\",\n        \"Link to the accumbal NPAS2/Drd3 transcriptional axis untested\"\n      ]\n    },\n    {\n      \"year\": 2022,\n      \"claim\": \"Connected DRD3 autophagy signaling to innate immune control, showing Drd3-dependent autophagy suppresses astrocytic NLRP3 inflammasome activity and confers neuroprotection.\",\n      \"evidence\": \"Drd3 siRNA in primary astrocytes, NLRP3 stimulation, autophagy markers, astrocyte-specific Atg5 knockdown in a mouse PD model\",\n      \"pmids\": [\"35896696\"],\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"\",\n      \"gaps\": [\n        \"Whether endogenous dopaminergic tone engages this astrocytic pathway is untested\",\n        \"Link between the AMPK-MTORC1 autophagy cascade and NLRP3 suppression not directly traced\"\n      ]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"How DRD3's palmitoylation/GIPC1 trafficking switch, its AMPK-autophagy signaling, and its circuit-specific roles in social behavior and reward are integrated into a unified receptor-level mechanism remains open.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"\",\n      \"gaps\": [\n        \"No structural model linking palmitoylation state to specific signaling outputs\",\n        \"Whether biased signaling controls the autophagy versus circuit-plasticity branches is unknown\"\n      ]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0060089\", \"supporting_discovery_ids\": [0, 1, 3]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005886\", \"supporting_discovery_ids\": [5]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-162582\", \"supporting_discovery_ids\": [0, 1, 3]},\n      {\"term_id\": \"R-HSA-9612973\", \"supporting_discovery_ids\": [3, 4]},\n      {\"term_id\": \"R-HSA-168256\", \"supporting_discovery_ids\": [4]},\n      {\"term_id\": \"R-HSA-9909396\", \"supporting_discovery_ids\": [2]}\n    ],\n    \"complexes\": [],\n    \"partners\": [\"GIPC1\"],\n    \"other_free_text\": []\n  }\n}","audit_flag":null,"evaluation":{"pairwise":"win","faith_supported":5,"faith_total":5,"faith_pct":100.0}}